Operator of an online skincare platform designed to provide prescription-oriented acne and anti-aging treatments.
Operator of an online skincare platform designed to provide prescription-oriented acne and anti-aging treatments.
Clinics/Outpatient Services📍 San Diego, CAFounded 2014
Current Valuation
$831.8M
as of 2019-Q4
PRIVATE
QL Price
$1.1B
+29% vs last round
QuantLogix's current estimate for Curology, published 2026-09-27 — above the last disclosed round of $831.8M (2019-Q4).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$831.8M
2019-Q4
weight 0.01
Secondary market print
$1.1B
2026-06-27
weight 0.58
How this price has held up
No round has priced for Curology since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Curology, 2026-09-27 (d983f052b485bf08).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Curology going public?
No. Curology is private and has not filed to go public. There is no S-1 on file.
What is Curology's valuation in 2026?
Curology is valued at $831.8M as of 2019-Q4, set by its Later Stage VC ($31.8M, Nov 2019). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Curology filed an S-1?
No public S-1 is on file for Curology.
How much has Curology raised?
Curology has raised $61.65M in total, most recently a Later Stage VC of $31.8M in Nov 2019.
Is Curology publicly traded — can you buy Curology stock?
No. Curology is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Curology on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2014
HQ
San Diego, CA
Employees
206
Total Raised
$61.65M
Last Round
Later Stage VC — $31.8M (Nov 2019)
IPO Status
private
Fundraising Status
Later Stage VC · $31.8M · 6y 10mo ago
privateTotal raised $61.65M
Secondary Market
Implied price / share
$3.85
Last round price / share
$2.97
vs last round
+29.6%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$31.8M
Nov 2019
—
$831.8M
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
1
via workable
Product-build share
0%
engineering, research, product, design
Trajectory
steady
go-to-market push — Only 0% of open roles build product — hiring is concentrated in sales/marketing/ops (1 of 1 open roles are other).
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
CRM Manager - Contract
Counted from Curology's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
BeautyHealth CareCosmeticsConsumer Goods
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2019-Q4. Refreshed quarterly.